EVALUATION OF CIRCULATING TUMOUR CELLS (CTCS) IN SMALL CELL LUNG CANCER (SCLC) PATIENTS UNDERGOING CHEMOTHERAPY

被引：0
|
作者：
Hou, J. [1 ]
Greystoke, A. [1 ]
Williamson, A. [2 ]
Lancashire, L. [2 ]
Ashcroft, L. F. [3 ]
Lorigan, P. [4 ]
Hughes, S. [2 ]
Dive, C. [1 ]
Blackhall, F. H. [4 ]
机构：
[1] Paterson Inst Canc Res, Manchester M20 9BX, Lancs, England
[2] PICR, Cep, Manchester, Lancs, England
[3] Christie Hosp, Dept Biostat, Manchester, Lancs, England
[4] Christie Hosp, Dept Med Oncol, Manchester, Lancs, England
来源：
ANNALS OF ONCOLOGY | 2008年 / 19卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：252 / 252
页数：1
相关论文
共 50 条
  • [31] Detection of Circulating Tumour Cells and Survival of Patients with Non-small Cell Lung Cancer
    Chudasama, Dimple
    Barr, James
    Beeson, Julie
    Beddow, Emma
    Mcgonigle, Niall
    Rice, Alexandra
    Nicholson, Andrew
    Anikin, Vladimir
    ANTICANCER RESEARCH, 2017, 37 (01) : 169 - 173
  • [32] Characterization of DLL3-positive circulating tumor cells (CTCs) in patients with small cell lung cancer (SCLC) and evaluation of their clinical relevance during front-line treatment.
    Messaritakis, Ippokratis
    Nikolaou, Michail
    Koinis, Filippos
    Politaki, Eleni
    Koutsopoulos, Anastasios
    Lagoudaki, Eleni
    Georgoulias, Vassilis
    Kotsakis, Athanasios
    JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)
  • [33] Characteristics of circulating tumor cells (CTCs) in patients with lung cancer
    Vlajnic, T.
    Brady, L.
    Casey, O.
    Gately, K.
    Barr, M. P.
    Cuffe, S.
    Bubendorf, L.
    Finn, S.
    JOURNAL OF THORACIC ONCOLOGY, 2016, 11 (04) : S66 - S66
  • [34] A combination chemotherapy of carboplatin and irinotecan in elderly patients with small cell lung cancer (SCLC).
    Okamoto, H
    Kudoh, H
    Nagatomo, A
    Kunikane, H
    Watanabe, K
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 669S - 669S
  • [35] Why do some patients with small cell lung cancer (SCLC) not get chemotherapy?
    Mackean, M.
    Allen, A.
    Price, A.
    Ironside, J.
    Erridge, S.
    Campbell, S.
    Patrizio, A.
    Fergusson, R.
    LUNG CANCER, 2012, 75 : S59 - S59
  • [36] Biomarkers for small cell lung cancer: Neuroendocrine, epithelial and circulating tumour cells
    Stovold, Rachel
    Blackhall, Fiona
    Meredith, Suzanne
    Hou, JianMei
    Dive, Caroline
    White, Anne
    LUNG CANCER, 2012, 76 (03) : 263 - 268
  • [37] A retrospective evaluation of metformin usage in patients with small cell lung cancer (SCLC).
    Mellema, Wouter W.
    Aarts, Mieke J.
    Van Herk-Sukel, Myrthe P. P.
    Smit, Egbert F.
    CANCER RESEARCH, 2013, 73 (08)
  • [38] Circulating deoxyribonucleic acid as prognostic marker in non-small-cell lung cancer patients undergoing chemotherapy
    Gautschi, O
    Bigosch, C
    Huegli, B
    Jermann, M
    Marx, A
    Chassé, E
    Ratschiller, D
    Weder, W
    Joerger, M
    Betticher, DC
    Stahel, RA
    Ziegler, A
    JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (20) : 4157 - 4164
  • [39] A national survey of chemotherapy (CT) in small cell lung cancer (SCLC)
    Sambrook, RJ
    Girling, DJ
    THORAX, 1999, 54 : A14 - A14
  • [40] Third-line chemotherapy for small cell lung cancer (SCLC)
    de Jong, W
    ten Hacken, N
    Groan, H
    LUNG CANCER, 2005, 49 : S317 - S318
12345